Press release article from our research archive:
|
|
Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity.
- Article from:
-
PR Newswire
- Article date:
-
January 8, 2008
|
Copyright informationCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOTHELL, Wash., Jan. 8 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. announced the completion of enrollment for its Phase 2 clinical trial of PYY3-36 Nasal Spray to treat obesity. The Company enrolled 551 obese patients at multiple clinical sites in the United States for a six-month, randomized, placebo-controlled dose ranging study. The study is designed to evaluate three different doses of PYY3-36 Nasal Spray compared to placebo and sibutramine (Meridia(R)), a commercially available oral weight loss drug, with the primary endpoint being weight loss.
"We are pleased with the rapid enrollment of 551 patients into the Phase 2 study to evaluate PYY3-36 ...
Related newspaper, magazine, and journal articles:
|
NASTECH SEALS DEAL WITH P&G - SHARES JUMP A MULTIMILLION-DOLLAR LINKUP ON...
Seattle Post-Intelligencer (Seattle, WA);
February 2, 2006 ;
620 words
......to develop a nasal spray for osteoporosis...regular trading, Nastech shares closed...non-vertebral fractures. Nastech hopes more patients...will accept its nasal spray version of the...consulted for Nastech but not for this nasal spray. The money will...
|
|
Merck Partners on Nasal Spray Obesity Drug
AP Online;
September 28, 2004 ;
700+ words
......small-scale testing of a nasal spray drug designed to...feel full faster. Nastech Pharmaceutical...premier company." Nastech does not have any...Peptide YY 3-36 Nasal Spray, is a synthetic...tests showed the nasal spray was well tolerated...well as costs for ...
|
|
Nasal spray next weapon in obesity
Deseret News (Salt Lake City);
September 28, 2004 ;
700+ words
......small-scale testing of a nasal spray drug designed to...feel full faster. Nastech Pharmaceutical...premier company." Nastech does not have any...Peptide YY 3-36 Nasal Spray, is a synthetic...tests showed the nasal spray was well tolerated...well as costs for ...
|
|
Nastech Pharmaceutical Company Inc. and Procter & Gamble Announce...
PR Newswire;
February 1, 2006 ;
700+ words
......and commercialize Nastech's Parathyroid Hormone (PTH1-34) nasal spray for the treatment...were disclosed. Nastech and P&G will...develop PTH1-34 nasal spray, and P&G will reimburse Nastech for any development...partner PTH1-34 nasal spray as it ...
|
|
Nastech Pharmaceutical Company Inc. and Procter & Gamble Announce...
PR Newswire Europe;
February 1, 2006 ;
700+ words
......and commercialize Nastech's Parathyroid Hormone (PTH1-34) nasal spray for the treatment...were disclosed. Nastech and P&G will...develop PTH1-34 nasal spray, and P&G will reimburse Nastech for any development...partner PTH1-34 nasal spray as it ...
|
|
Nastech Enters Into Supply Agreement with Procter & Gamble for Parathyroid...
PR Newswire;
June 6, 2006 ;
700+ words
......agreement for PTH1-34 nasal spray that was announced...supply agreement, Nastech will be the exclusive...of the PTH1-34 nasal spray for P&G and...agreement with Nastech as it secures sufficient...commercialization of PTH1-34 nasal spray, if approved, said...February ...
|
|
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical...
PR Newswire;
September 26, 2007 ;
700+ words
......Rapid-Acting, Non-Invasive Nasal Spray Dosage form is Patient...PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company...different doses of Nastech's Insulin Nasal Spray compared to NovoLog...begin in October. Nastech's Insulin Nasal Spray has the potential...
|
|
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical...
PR Newswire;
October 1, 2007 ;
700+ words
......different doses of Nastech's PYY3-36 Nasal Spray compared to placebo...clinicaltrials.gov/. Nastech has developed a...friendly, non-invasive nasal spray dosage form of a...delivery technology, Nastech developed the nasal spray formulation of PYY...
|
|
Nastech Provides Calcitonin Salmon Nasal Spray Complete Response to FDA.
PR Newswire;
September 29, 2006 ;
700+ words
......preservative in Nastech's salmon calcitonin nasal spray formulation. Nastech's response...filing. Nastech's formulation...calcitonin-salmon nasal spray was specifically...calcitonin-salmon nasal spray, Miacalcin...ANDA. Thus, Nastech's formulation...
|
|
Nastech to Manufacture Nascobal(R) Nasal Spray for QOL Medical.
PR Newswire;
October 17, 2005 ;
700+ words
......Cyanocobalamin, USP) Nasal Spray for the treatment...Pharmaceuticals, Inc. , Nastech will be the...identified in Nastech's NDA for Nascobal Nasal Spray. Additional...supplying Nascobal Nasal Spray to QOL and will...Financial Officer of Nastech. About Nascobal...
|
|
Nastech Submits Investigational New Drug Application for PYY3-36 Nasal...
PR Newswire;
June 7, 2006 ;
693 words
......potential for PYY nasal spray to treat obesity...President and CEO of Nastech. We have been...delivery technology, Nastech developed the nasal spray formulation of...hypertension. PYY nasal spray may offer a novel...condition. About Nastech Nastech is a...
|
|
Nastech's Facility Approved for Commercial Manufacturing of...
PR Newswire;
February 28, 2006 ;
700+ words
......PAI enables Nastech to manufacture calcitonin-salmon nasal spray for commercial...necessary to bring Nastech's calcitonin-salmon nasal spray to the market...calcitonin-salmon nasal spray, Miacalcin(R) and Nastech's nasal spray product, is...
|
|
Nastech Reports Positive PYY Nasal Spray Clinical Trial Data and Will...
PR Newswire;
December 21, 2006 ;
700+ words
......Intravenous and PYY Nasal Spray Produce Satiety...FirstCall/ -- Nastech Pharmaceutical...various doses of Nastech's proprietary PYY(3-36) nasal spray in obese subjects...delivery technology, Nastech developed the nasal spray formulation of...
|
See all results.
Or, try our
Advanced Search.
|